{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:17:08Z","timestamp":1790709428678,"version":"4.1.0"},"reference-count":33,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2023.13979","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T12:00:25Z","timestamp":1690459225000},"source":"Crossref","is-referenced-by-count":3,"title":["SHP2 is involved in the occurrence, development and prognosis of cancer"],"prefix":"10.3892","volume":"26","author":[{"given":"Shu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Women and Children's Hospital of Chongqing Medical University, Chongqing Health Center for Women and Children, Chongqing 401174, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Women and Children's Hospital of Chongqing Medical University, Chongqing Health Center for Women and Children, Chongqing 401174, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing Health Center for Women and Children, Chongqing 401174, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Women and Children's Hospital of Chongqing Medical University, Chongqing Health Center for Women and Children, Chongqing 401174, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Women and Children's Hospital of Chongqing Medical University, Chongqing Health Center for Women and Children, Chongqing 401174, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"key20230830194321_b1-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"13273","DOI":"10.2147\/CMAR.S270813","article-title":"SHP-2 Interacts with CD81 and regulates the malignant evolution of colorectal cancer by inhibiting epithelial-mesenchymal transition","volume":"12","author":"Yuan","year":"2020","journal-title":"Cancer Manag Res"},{"key":"key20230830194321_b2-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"107807","DOI":"10.1016\/j.jmgm.2020.107807","article-title":"Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2WT and SHP2F285S by molecular dynamics study","volume":"103","author":"Zhou","year":"2021","journal-title":"J Mol Graph Model"},{"key":"key20230830194321_b3-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/cmdc.202000706","article-title":"Small-Molecule Inhibitors of Shp2 phosphatase as potential chemotherapeutic agents for Glioblastoma: A Minireview","volume":"16","author":"Mitra","year":"2021","journal-title":"ChemMedChem"},{"key":"key20230830194321_b4-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/ol.2022.13605","article-title":"Role of SHP2\/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta-analysis","volume":"25","author":"Li","year":"2023","journal-title":"Oncol Lett"},{"key":"key20230830194321_b5-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s10620-009-0924-z","article-title":"Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas","volume":"55","author":"Kim","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key20230830194321_b6-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2020.11.007","article-title":"Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment","volume":"62","author":"Kerr","year":"2021","journal-title":"Curr Opin Chem Biol"},{"key":"key20230830194321_b7-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1038\/onc.2014.170","article-title":"Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases","volume":"34","author":"Sausgruber","year":"2015","journal-title":"Oncogene"},{"key":"key20230830194321_b8-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41591-018-0023-9","article-title":"SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo","volume":"24","author":"Mainardi","year":"2018","journal-title":"Nat Med"},{"key":"key20230830194321_b9-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00432-011-1143-5","article-title":"The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma","volume":"138","author":"Jiang","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20230830194321_b10-ol-26-3-13979","first-page":"485","article-title":"Role of CAD gene in the prognosis evaluation of pan-cancer","volume":"33","author":"Xinhua","year":"2020","journal-title":"J Basic Clinical Oncol"},{"key":"key20230830194321_b11-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12935-020-1113-6","article-title":"Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int"},{"key":"key20230830194321_b12-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"key":"key20230830194321_b13-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.immuni.2019.08.004","article-title":"The Immune landscape of cancer","volume":"51","author":"Thorsson","year":"2019","journal-title":"Immunity"},{"key":"key20230830194321_b14-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3892\/ijo.2013.2191","article-title":"SHP2 promotes laryngeal cancer growth through the Ras\/Raf\/Mek\/Erk pathway and serves as a prognostic indicator for laryngeal cancer","volume":"44","author":"Gu","year":"2014","journal-title":"Int J Oncol"},{"key":"key20230830194321_b15-ol-26-3-13979","first-page":"25113","article-title":"Novel Small-molecule inhibitor for the oncogenic tyrosine phosphatase SHP2 with anti-breast cancer cell effects","volume":"5","author":"Chalfant","year":"2020","journal-title":"Mol Cancer Res"},{"key":"key20230830194321_b16-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10637-018-0626-5","article-title":"Inhibition of SHP2 by new compounds induces differential effects on RAS\/RAF\/ERK and PI3K\/AKT pathways in different cancer cell types","volume":"37","author":"Vazhappilly","year":"2019","journal-title":"Invest New Drugs"},{"key":"key20230830194321_b17-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.celrep.2018.12.013","article-title":"SHP2 Drives adaptive resistance to ERK signaling inhibition in molecularly defined subsets of ERK-Dependent tumors","volume":"26","author":"Ahmed","year":"2019","journal-title":"Cell Rep"},{"key":"key20230830194321_b18-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/2159-8290.CD-18-0444","article-title":"SHP2 inhibition prevents adaptive resistance to MEK inhibitors in multiple cancer models","volume":"8","author":"Fedele","year":"2018","journal-title":"Cancer Discov"},{"key":"key20230830194321_b19-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1111\/1759-7714.14137","article-title":"High SHP2 expression determines the efficacy of PD-1\/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer","volume":"12","author":"Feng","year":"2021","journal-title":"Thorac Cancer"},{"key":"key20230830194321_b20-ol-26-3-13979","first-page":"7692","article-title":"Expression and clinical significance of Shp2 protein in breast cancer","volume":"32","author":"Lei","year":"2011","journal-title":"Jilin Med J"},{"key":"key20230830194321_b21-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.2147\/OTT.S138833","article-title":"SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo","volume":"10","author":"Hu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"key20230830194321_b22-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-020-01818-1","article-title":"PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2\/Ras\/MAPK signalling in thyroid cancer cells","volume":"40","author":"Liotti","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"key20230830194321_b23-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"e2035479","DOI":"10.1001\/jamanetworkopen.2020.35479","article-title":"Assessment of RAS dependency for BRAF alterations using cancer genomic databases","volume":"4","author":"Zhao","year":"2021","journal-title":"JAMA Netw Open"},{"key":"key20230830194321_b24-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"11368","DOI":"10.1021\/acs.jmedchem.0c00249","article-title":"Recent advances of SHP2 inhibitors in cancer therapy: Current development and clinical application","volume":"63","author":"Yuan","year":"2020","journal-title":"J Med Chem"},{"key":"key20230830194321_b25-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3390\/ijms19092708","article-title":"Protein tyrosine phosphatases as potential regulators of STAT3 signaling","volume":"19","author":"Kim","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20230830194321_b26-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"22353","DOI":"10.1074\/jbc.M109.020495","article-title":"Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"key20230830194321_b27-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-20-1365","article-title":"Combined inhibition of SHP2 and MEK is effective in models of NF1-Deficient malignant peripheral nerve sheath tumors","volume":"80","author":"Wang","year":"2020","journal-title":"Cancer Res"},{"key":"key20230830194321_b28-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cell.2020.09.002","article-title":"Phase separation of disease-associated SHP2 mutants underlies MAPK hyperactivation","volume":"183","author":"Zhu","year":"2020","journal-title":"Cell"},{"key":"key20230830194321_b29-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/CAD.0000000000001055","article-title":"Demonstrating the effect of SHP2 inhibitor on cervical squamous cell carcinoma from the perspective of ZAP70","volume":"32","author":"Gong","year":"2021","journal-title":"Anticancer Drugs"},{"key":"key20230830194321_b30-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: Therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"key20230830194321_b31-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.20181198","article-title":"Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10","volume":"216","author":"Xiao","year":"2019","journal-title":"J Exp Med"},{"key":"key20230830194321_b32-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"key20230830194321_b33-ol-26-3-13979","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/2159-8290.CD-18-0915","article-title":"Shipping out MEK inhibitor resistance with SHP2 inhibitors","volume":"8","author":"Torres-Ayuso","year":"2018","journal-title":"Cancer Discov"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T16:44:41Z","timestamp":1693413881000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2023.13979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,7,27]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2023.13979","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"article-number":"393"}}